Drug Dealin Podcast Archive

I have the pleasure of co-hosting a podcast with my fellow Biopharma insider, Kenny Lalwani. Every episode we pull back the curtain on key questions and hot topics in the space, offering unparalleled insider insights. Each episode features in-depth discussions and interviews with industry luminaries, giving you honest and unvarnished perspectives you won’t find anywhere else.

You can subscribe to Drug Dealin on your podcast platform of choice (Youtube | Spotify | Apple) or on BigPharmaSharma.com where I will also publish every episode.

Below is a repository of every episode we’ve recorded, with links to listen on BigPharmaSharma.com:

• Episode 7 (11/20/25): Biotech M&A Insights

  CVRs, Patent Cliffs & The Pfizer-Novo Bidding War

• Episode 6 (9/9/25): Should the FDA Be Independent?

  Given the recent FDA Drama, what if the FDA operated more like the FED?

• Episode 5 (7/1/25): How to Talk to Doctors | Feat. Joe McCann, Co-Founder/CEO of Slingshot Insights

  How to prepare for, ask questions, and get more out of your engagements with doctors, whether you’re an investor, biotech pro, or a patient

• Episode 4 (6/19/25): Ozempic for the Brain, A New Era to Explain

  the evolving landscape of GLP-1 drugs, particularly focusing on the recent advancements in oral formulations and their potential applications beyond diabetes and obesity

• Episode 3 (3/10/25): Rise of the Phoenix | Sujal Shah & CymaBay Therapeutics

  Interview with Sujal Shah, CEO of CymBay Therapeutics (acquired by Gilead) about the company’s roller coaster journey and perseverance through adversity.

• Episode 2 (1/10/25): Predictions for Biopharma in 2025

  Three predictions each for Biopharma in 2025

• Episode 1 (1/10/25): Do Pharma companies avoid cures?

  Debunking the myth that BioPharma companies avoid curing patients because it is more profitable